NCT00630851 - A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes | Biotech Hunter

Enrollment

249

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

October 31, 2004

Conditions

Alzheimer Disease

Interventions

DRUG

Donepezil (Aricept)

Donepezil (Aricept) 5 mg tablet orally once daily for 30 days, followed by 10 mg tablet orally once daily to complete 6 months of treatment

DRUG

Placebo

Matching placebo tablets orally once daily for 6 months

Trial Locations (53)

13521

Pfizer Investigational Site, Tyreso

33185

Pfizer Investigational Site, Värnamo

43323

Pfizer Investigational Site, Partille

510 29

Pfizer Investigational Site, Fritsla

747 30

Pfizer Investigational Site, Alunda

578 21

Pfizer Investigational Site, Aneby

774 82

Pfizer Investigational Site, Avesta

184 33 AKERSBERGA

Pfizer Investigational Site, Åkersberga

120 54

Pfizer Investigational Site, Årsta

666 30

Pfizer Investigational Site, Bengtsfors

820 70

Pfizer Investigational Site, Bergsjö

931 64

Pfizer Investigational Site, Boden

781 27

Pfizer Investigational Site, Borlänge

693 22

Pfizer Investigational Site, Degerfors

631 88

Pfizer Investigational Site, Eskilstuna

632 23

Pfizer Investigational Site, Eskilstuna

332 30

Pfizer Investigational Site, Gislaved

412 75

Pfizer Investigational Site, Gothenburg

547 31

Pfizer Investigational Site, Gullspång

134 30

Pfizer Investigational Site, Gustavsberg

776 28

Pfizer Investigational Site, Hedemora

254 43

Pfizer Investigational Site, Helsingborg

360 44

Pfizer Investigational Site, Ingelstad

553 16

Pfizer Investigational Site, Jönköping

952 82

Pfizer Investigational Site, Kalix

656 37

Pfizer Investigational Site, Karlstad

641 47

Pfizer Investigational Site, Katrineholm

681 29

Pfizer Investigational Site, Kristinehamn

531 85

Pfizer Investigational Site, Lidköping

205 02

Pfizer Investigational Site, Malmo

684 23

Pfizer Investigational Site, Munkfors

576 81

Pfizer Investigational Site, Nässjö

238 40

Pfizer Investigational Site, Oxie

831 31

Pfizer Investigational Site, Östersund

795 21

Pfizer Investigational Site, Rättvik

811 60

Pfizer Investigational Site, Sandviken

429 13

Pfizer Investigational Site, Särö

460 20

Pfizer Investigational Site, Sjuntorp

466 30

Pfizer Investigational Site, Sollebrunn

112 35

Pfizer Investigational Site, Stockholm

116 32

Pfizer Investigational Site, Stockholm

686 22

Pfizer Investigational Site, Sunne

461 59

Pfizer Investigational Site, Trollhättan

146 31

Pfizer Investigational Site, Tullinge

901 85

Pfizer Investigational Site, Umeå

194 04

Pfizer Investigational Site, Upplands Vasby

751 25

Pfizer Investigational Site, Uppsala

350 04

Pfizer Investigational Site, Vaxjo

352 41

Pfizer Investigational Site, Vaxjo

911 82

Pfizer Investigational Site, Vännäs

722 11

Pfizer Investigational Site, Västerås

621 84

Pfizer Investigational Site, Visby

Unknown

Pfizer Investigational Site